References
- Ibrahim R, Pasic M, Yousef GM. Omics for personalized medicine: defining the current we swim in. Expert Rev Mol Diagn. 2016;16(7):719–722.
- Rifai N, Topol E, Chan E, et al. Disruptive innovation in laboratory medicine. Clin Chem. 2015;61(9):1129–1132.
- Disruptive and sustaining innovation: Deloitte Israel; 2020. Available from: https://www2.deloitte.com/il/en/pages/innovation/article/disruptive_vs_sustaining.html#
- Koboldt DC, Steinberg KM, Larson DE, et al. The next-generation sequencing revolution and its impact on genomics. Cell. 2013;155(1):27–38.
- Murphy MJ. Automation in UK clinical biochemistry. Ann Clin Biochem. 2013;50(Pt 3):285–286.
- Jonsson B. Disruptive innovation and EU health policy. Eur J Health Econ. 2017;18(3):269–272.
- Galea S. Will disruptive innovation in health care improve the health of populations? Milbank Q. 2018;96(4):619–622.
- Bower JL, Christensen CM. Disruptive technologies: catching the wave. Harv Bus Rev. 1995;73(1):43–53.
- Hwang J, Christensen CM. Disruptive innovation in health care delivery: a framework for business-model innovation. Health Aff . 2008;27(5):1329–1335.
- Christensen CM, Bohmer R, Kenagy J. Will disruptive innovations cure health care? Harv Bus Rev. 2000;78(5):102–112.
- Christensen CM. The encyclopedia of human-computer interaction. 2nd ed. Aarhus, Denmark: Interaction Design Foundation.
- Team M. What is disruptive innovation: MJV technology & innovation; 2019. Available from: https://www.mjvinnovation.com/blog/disruptive-innovation/
- Wilson R, Godfrey CM, Sears K, et al. Exploring conceptual and theoretical frameworks for nurse practitioner education: a scoping review protocol. JBI Database System Rev Implement Rep. 2015;13(10):146–155.
- Hooker RS, Moloney-Johns AJ, McFarland MM. Patient satisfaction with physician assistant/associate care: an international scoping review. Hum Resour Health. 2019;17(1):104.
- Kleinpell RM, Grabenkort WR, Kapu AN, et al. Nurse practitioners and physician assistants in acute and critical care: a concise review of the literature and data 2008–2018. Crit Care Med. 2019;47(10):1442–1449.
- Polinski JM, Barker T, Gagliano N, et al. Patients’ satisfaction with and preference for telehealth visits. J Gen Intern Med. 2016;31(3):269–275.
- Medicine JH. Coronavirus (COVID-19) information and updates; 2020. Available from: https://www.hopkinsmedicine.org/coronavirus/index.html
- Alert C. Health Canada/Santé Canada; 2020. Available from: https://www.canada.ca/en/public-health/services/publications/diseases-conditions/covid-alert-app.html
- Tantibanchachai C. Researchers use machine learning to predict heart damage in COVID-19 patients. Baltimore (MD): Johns Hopkins University; 2020.
- Bradley R, Harnett J, Cooley K, et al. Naturopathy as a model of prevention-oriented, patient-centered primary care: a disruptive innovation in health care. Medicina. 2019;55(9):603.
- Dodd GD, 3rd, Restauri NL, Kondo KL, et al. Driving innovation in radiology: a summary of the 2015 intersociety committee summer conference. J Am Coll Radiol. 2016;13(12 Pt A):1477–1482.
- Gabril MY, Yousef GM. Informatics for practicing anatomical pathologists: marking a new era in pathology practice. Mod Pathol. 2010;23(3):349–358.
- Evans AJ, Chetty R, Clarke BA, et al. Primary frozen section diagnosis by robotic microscopy and virtual slide telepathology: the University Health Network experience. Semin Diagn Pathol. 2009;26(4):165–176.
- Evans AJ, Chetty R, Clarke BA, et al. Primary frozen section diagnosis by robotic microscopy and virtual slide telepathology: the University Health Network experience. Hum Pathol. 2009;40(8):1070–1081.
- Niazi MKK, Parwani AV, Gurcan MN. Digital pathology and artificial intelligence. Lancet Oncol. 2019;20(5):e253–e261.
- Griffin J, Treanor D. Digital pathology in clinical use: where are we now and what is holding us back? Histopathology. 2017;70(1):134–145.
- Williams BJ, Bottoms D, Treanor D. Future-proofing pathology: the case for clinical adoption of digital pathology. J Clin Pathol. 2017;70(12):1010–1018.
- Hart SN. Will digital pathology be as disruptive as genomics? J Pathol Inform. 2018;9:27.
- Vergani A, Regis B, Jocolle G, et al. Noninferiority diagnostic value, but also economic and turnaround time advantages from digital pathology. Am J Surg Pathol. 2018;42(6):841–842.
- Mirham L, Naugler C, Hayes M, et al. Performance of residents using digital images versus glass slides on certification examination in anatomical pathology: a mixed methods pilot study. CMAJ Open. 2016;4(1):E88–E94.
- Yousef GM. Navigation through a new age of digital pathology: promises and challenges. Can J Pathol. 2017;9(1):4–6.
- Fraggetta F, Garozzo S, Zannoni GF, et al. Routine digital pathology workflow: the Catania experience. J Pathol Inform. 2017;8:51.
- Retamero JA, Aneiros-Fernandez J, Del Moral RG. Complete digital pathology for routine histopathology diagnosis in a multicenter hospital network. Arch Pathol Lab Med. 2020;144(2):221–228.
- Stathonikos N, Nguyen TQ, Spoto CP, et al. Being fully digital: perspective of a Dutch academic pathology laboratory. Histopathology. 2019;75(5):621–635.
- Saffitz JE. Genomic pathology: a disruptive innovation. Per Med. 2012;9(3):237–239.
- Green ED, Watson JD, Collins FS. Human genome project: twenty-five years of big biology. Nature. 2015;526(7571):29–31.
- Collins FS, Morgan M, Patrinos A. The human genome project: lessons from large-scale biology. Science. 2003;300(5617):286–290.
- Diamandis M, White NM, Yousef GM. Personalized medicine: marking a new epoch in cancer patient management. Mol Cancer Res. 2010;8(9):1175–1187.
- Pasic MD, Samaan S, Yousef GM. Genomic medicine: new frontiers and new challenges. Clin Chem. 2013;59(1):158–167.
- Hwang SM, Lee KC, Lee MS, et al. Comparison of ion personal genome machine platforms for the detection of variants in BRCA1 and BRCA2. Cancer Res Treat. 2018;50(1):255–264.
- Zopf A, Raim R, Danzer M, et al. Introduction of the hybcell-based compact sequencing technology and comparison to state-of-the-art methodologies for KRAS mutation detection. Biotechniques. 2015;58(3):126–134.
- Kumar KR, Cowley MJ, Davis RL. Next-generation sequencing and emerging technologies. Semin Thromb Hemost. 2019;45(7):661–673.
- Technologies OO. Oxford nanopore technologies; 2020 November 25. Available from: https://nanoporetech.com/
- Lanevschi A, Kramer JW. Comparison of two dry chemistry analyzers and a wet chemistry analyzer using canine serum. Vet Clin Pathol. 1996;25(1):10–13.
- Flatland B, Breickner LC, Fry MM. Analytical performance of a dry chemistry analyzer designed for in-clinic use. Vet Clin Pathol. 2014;43(2):206–217.
- Goble JA, Rocafort PT. Point-of-care testing. J Pharm Pract. 2017;30(2):229–237.
- Ferreira CES, Guerra JCC, Slhessarenko N, et al. Point-of-care testing: general aspects. Clin Lab. 2018;64(1):1–9.
- Kost GJ, Shirey TL. New whole-blood testing for laboratory support of critical care at cardiac transplant centers and US hospitals. Arch Pathol Lab Med. 1990;114(8):865–868.
- Kricka LJ. Emerging and disruptive technologies. EJIFCC. 2016;27(3):253–258.
- Charles L, Nelson MKS, Jin RY, et al. Inventor; Abbott Diabetes Care Inc., assignee. Glucose measuring device for use in personal area network. Patent US9730584B2. 2017.
- Cole LA, Sutton-Riley JM, Khanlian SA, et al. Sensitivity of over-the-counter pregnancy tests: comparison of utility and marketing messages. J Am Pharm Assoc (2003). 2005;45(5):608–615.
- Balter ML, Leipheimer JM, Chen AI, et al. Automated end-to-end blood testing at the point-of-care: integration of robotic phlebotomy with downstream sample processing. Technology (Singap World Sci). 2018;6(2):59–66.
- Price CP, Smith I, Van den Bruel A. Improving the quality of point-of-care testing. Fam Pract. 2018;35(4):358–364.
- Hood L, Friend SH. Predictive, personalized, preventive, participatory (P4) cancer medicine. Nat Rev Clin Oncol. 2011;8(3):184–187.
- Naugler C, Church DL. Automation and artificial intelligence in the clinical laboratory. Crit Rev Clin Lab Sci. 2019;56(2):98–110.
- Yousef GM. Artificial intelligence: the best is yet to come. Can J Pathol. 2019;11(3):4.
- Beck AH, Sangoi AR, Leung S, et al. Systematic analysis of breast cancer morphology uncovers stromal features associated with survival. Sci Transl Med. 2011;3(108):108ra113.
- Nagpal K, Foote D, Liu Y, et al. Development and validation of a deep learning algorithm for improving Gleason scoring of prostate cancer. NPJ Digit Med. 2019;2:48.
- Parwani AV. Next generation diagnostic pathology: use of digital pathology and artificial intelligence tools to augment a pathological diagnosis. Diagn Pathol. 2019;14(1):138.
- Cruz-Roa A, Gilmore H, Basavanhally A, et al. Accurate and reproducible invasive breast cancer detection in whole-slide images: a deep learning approach for quantifying tumor extent. Sci Rep. 2017;7:46450.
- Hegde N, Hipp JD, Liu Y, et al. Similar image search for histopathology: SMILY. NPJ Digit Med. 2019;2:56.
- Ngiam KY, Khor IW. Big data and machine learning algorithms for health-care delivery. Lancet Oncol. 2019;20(5):e262–e273.
- Olivera P, Danese S, Jay N, et al. Big data in IBD: a look into the future. Nat Rev Gastroenterol Hepatol. 2019;16(5):312–321.
- Perco P, Oberbauer R. Integrative analysis of -omics data and histologic scoring in renal disease and transplantation: renal histogenomics. Semin Nephrol. 2010;30(5):520–530.
- Perco P, Kainz A, Wilflingseder J, et al. Histogenomics: association of gene expression patterns with histological parameters in kidney biopsies. Transplantation. 2009;87(2):290–295.
- Chetty R. Pathology and radiology taking medical ‘hermeneutics’ to the next level? J Clin Pathol. 2017;70(7):553–554.
- Filice RW. Deep-learning language-modeling approach for automated, personalized, and iterative radiology-pathology correlation. J Am Coll Radiol. 2019;16(9 Pt B):1286–1291.
- Barsoum I, Tawedrous E, Faragalla H, et al. Histo-genomics: digital pathology at the forefront of precision medicine. Diagnosis. 2019;6(3):203–212.
- Yousef GM. Use of social media in pathology: threats and opportunities. Can J Pathol. 2019;11(4):4.
- Isom J, Walsh M, Gardner JM. Social media and pathology: where are we now and why does it matter? Adv Anat Pathol. 2017;24(5):294–303.
- Bellis M, Metias S, Naugler C, et al. Digital pathology: attitudes and practices in the Canadian pathology community. J Pathol Inform. 2013;4:3.
- Yousef AG, Shipilova I, Kelada B, et al. Social media and digital resources in pathology: current attitudes and future perspectives for implementation. Can. J Pathol. 2019;11(3):51–62.
- ImmunoQuery. Available from: https://www.immunoquery.com/
- Tissue pathology. Available from: https://tissuepathology.com/
- Doximity. Available from: https://www.doximity.com/
- Yousef GM. Navigating through a new age of digital pathology: promises and challenges. Can. J Pathol. 2019;9(1):4–6.
- Saenger AK, Berkwits M, Carley S, et al. The power of social media in medicine and medical education: opportunities, risks, and rewards. Clin Chem. 2018;64(9):1284–1290.
- Nix JS, Gardner JM, Costa F, et al. Neuropathology education using social media. J Neuropathol Exp Neurol. 2018;77(6):454–460.
- bioRxiv. Available from: https://www.biorxiv.org/
- Yousef GM. Publicly available data: a game changer in modern research? Can J Pathol. 2018;10(3):4.
- Lee R, Davies G. Technology: the cure for rising healthcare costs? MIT Technology Review. 2013.
- Enthoven AC. Integrated delivery systems: the cure for fragmentation. Am J Manag Care. 2009;15(10):S284–S90.
- Flores M, Glusman G, Brogaard K, et al. P4 medicine: how systems medicine will transform the healthcare sector and society. Per Med. 2013;10(6):565–576.
- Brandao M, Ponde N, Piccart-Gebhart M. Mammaprint™: a comprehensive review. Future Oncol. 2019;15(2):207–224.
- Di Meo A, Bartlett J, Cheng Y, et al. Liquid biopsy: a step forward towards precision medicine in urologic malignancies. Mol Cancer. 2017;16(1):80.
- Di Meo A, Brown MD, Finelli A, et al. Prognostic urinary miRNAs for the assessment of small renal masses. Clin Biochem. 2020;75:15–22.
- Di Meo A, Batruch I, Brown MD, et al. Identification of prognostic biomarkers in the urinary peptidome of the small renal mass. Am J Pathol. 2019;189(12):2366–2376.
- Berry R. Will 3D printing make obsolescence obsolete? 2015. Available from: https://3dprint.com/60963/3d-printing-obsolete/
- Singh A. Digital imaging and anatomic pathology’s care delivery model: biomagene. Available from: https://www.executivewarcollege.com/wp-content/uploads/2012/03/Singh-1.pdf
- Mamuszka H. The neverending LDT vs IVD debate: the journal of precision medicine. Available from: https://www.thejournalofprecisionmedicine.com/wp-content/uploads/2019/06/jpm219-Mamuszka.pdf
- Genzen JR, Mohlman JS, Lynch JL, et al. Laboratory-developed tests: a legislative and regulatory review. Clin Chem. 2017;63(10):1575–1584.
- Lieberman JA, Pepper G, Naccache SN, et al. Comparison of commercially available and laboratory-developed assays for in vitro detection of SARS-CoV-2 in clinical laboratories. J Clin Microbiol. 2020;58(8):e00821-20.
- Genzen JR. Regulation of laboratory-developed tests. Am J Clin Pathol. 2019;152(2):122–131.
- (FDA) TFaDA. Discussion paper on laboratory developed tests (LDTs); 2017 January 13. Available from: https://www.fda.gov/media/102367/download.
- Yousef GM. Direct-to-consumer genetic testing: the fine line between helping and hurting. Can J Pathol. 2019;11(1):4.
- Nam SH. Why disruptive innovations matter in laboratory diagnostics. Clin Chem. 2015;61(7):935–937.
- Heitzer E, Haque IS, Roberts CES, et al. Current and future perspectives of liquid biopsies in genomics-driven oncology. Nat Rev Genet. 2019;20(2):71–88.
- Yousef GM. Academic industrial relationship: a symbiotic future. Can J Pathol. In Press.
- Etzkowitz H, Leydesdorff L. The dynamics of innovation: from National Systems and ‘‘Mode 2’’ to a Triple Helix of university–industry–government relations. NH Elsevier. 2000;29(2):109–123.
- SBIR. Available from: https://www.sbir.gov/about
- Canadian Cancer Society. Available from: https://www.cancer.ca/en/research/grants-and-awards/current-funding-opportunities/innovation-grants/
- COVID-19 update: FDA authorizes first diagnostic test where results can be read directly from testing card: food and arug administration (FDA). Available from: https://www.fda.gov/news-events/press-announcements/covid-19-update-fda-authorizes-first-diagnostic-test-where-results-can-be-read-directly-testing-card#:∼:text=Silver%20Spring%2C%20MD%20%2D%2D%20Today,design%20to%20some%20pregnancy%20tests
- Cambridge Innovation Center. Available from: https://cic.com/
- Toronto Innovation Acceleration Partners. Available from: https://tiap.ca/
- Veta M, van Diest PJ, Willems SM, et al. Assessment of algorithms for mitosis detection in breast cancer histopathology images. Med Image Anal. 2015;20(1):237–248.
- Ehteshami Bejnordi B, Veta M, Johannes van Diest P, et al. Diagnostic assessment of deep learning algorithms for detection of lymph node metastases in women with breast cancer. JAMA. 2017;318(22):2199–2210.
- Precision FDA challenges – precision FDA. Available from: http://www.precision.fda.gov/challenges
- Roche tissue diagnostics. Available from: https://diagnostics.roche.com/global/en/about/roche-tissue-diagnostics.html